Cargando…

Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?

Background: The application of heart rate variability is problematic in patients with atrial fibrillation (AF). This study aims to explore the associations between all-cause mortality and the median hourly ambulatory heart rate range ([Formula: see text]) compared with other parameters obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsing-Yu, Malik, John, Wu, Hau-Tieng, Wang, Chun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622712/
https://www.ncbi.nlm.nih.gov/pubmed/34834554
http://dx.doi.org/10.3390/jpm11111202
_version_ 1784605758225121280
author Chen, Hsing-Yu
Malik, John
Wu, Hau-Tieng
Wang, Chun-Li
author_facet Chen, Hsing-Yu
Malik, John
Wu, Hau-Tieng
Wang, Chun-Li
author_sort Chen, Hsing-Yu
collection PubMed
description Background: The application of heart rate variability is problematic in patients with atrial fibrillation (AF). This study aims to explore the associations between all-cause mortality and the median hourly ambulatory heart rate range ([Formula: see text]) compared with other parameters obtained from the Holter monitor in patients with newly diagnosed AF. Material and Methods: A total of 30 parameters obtained from 521 persistent AF patients’ Holter monitor were analyzed retrospectively from 1 January 2010 to 31 July 2014. Every patient was followed up to the occurrence of death or the end of 30 June 2017. Results: [Formula: see text] was the most feasible Holter parameter. Lower [Formula: see text] was associated with increased risk of all-cause mortality (adjusted hazard ratio [aHR] for every 10-bpm reduction: 2.70, 95% confidence interval [CI]: 1.75–4.17, p < 0.001). The C-statistic of [Formula: see text] alone was 0.707 (95% CI: 0.658–0.756), and 0.697 (95% CI: 0.650–0.744) for the CHA2DS2-VASc score alone. By combining [Formula: see text] with the CHA2DS2-VASc score, the C-statistic could improve to 0.764 (95% CI: 0.722–0.806). While using 20 bpm as the cut-off value, the aHR was 3.66 (95% CI: 2.05–6.52) for patients with [Formula: see text] < 20 bpm in contrast to patients with [Formula: see text] ≥ 20 bpm. Conclusions: [Formula: see text] could be helpful for risk stratification for AF in addition to the CHA2DS2-VASc score.
format Online
Article
Text
id pubmed-8622712
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86227122021-11-27 Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients? Chen, Hsing-Yu Malik, John Wu, Hau-Tieng Wang, Chun-Li J Pers Med Article Background: The application of heart rate variability is problematic in patients with atrial fibrillation (AF). This study aims to explore the associations between all-cause mortality and the median hourly ambulatory heart rate range ([Formula: see text]) compared with other parameters obtained from the Holter monitor in patients with newly diagnosed AF. Material and Methods: A total of 30 parameters obtained from 521 persistent AF patients’ Holter monitor were analyzed retrospectively from 1 January 2010 to 31 July 2014. Every patient was followed up to the occurrence of death or the end of 30 June 2017. Results: [Formula: see text] was the most feasible Holter parameter. Lower [Formula: see text] was associated with increased risk of all-cause mortality (adjusted hazard ratio [aHR] for every 10-bpm reduction: 2.70, 95% confidence interval [CI]: 1.75–4.17, p < 0.001). The C-statistic of [Formula: see text] alone was 0.707 (95% CI: 0.658–0.756), and 0.697 (95% CI: 0.650–0.744) for the CHA2DS2-VASc score alone. By combining [Formula: see text] with the CHA2DS2-VASc score, the C-statistic could improve to 0.764 (95% CI: 0.722–0.806). While using 20 bpm as the cut-off value, the aHR was 3.66 (95% CI: 2.05–6.52) for patients with [Formula: see text] < 20 bpm in contrast to patients with [Formula: see text] ≥ 20 bpm. Conclusions: [Formula: see text] could be helpful for risk stratification for AF in addition to the CHA2DS2-VASc score. MDPI 2021-11-14 /pmc/articles/PMC8622712/ /pubmed/34834554 http://dx.doi.org/10.3390/jpm11111202 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Hsing-Yu
Malik, John
Wu, Hau-Tieng
Wang, Chun-Li
Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title_full Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title_fullStr Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title_full_unstemmed Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title_short Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?
title_sort is the median hourly ambulatory heart rate range helpful in stratifying mortality risk among newly diagnosed atrial fibrillation patients?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622712/
https://www.ncbi.nlm.nih.gov/pubmed/34834554
http://dx.doi.org/10.3390/jpm11111202
work_keys_str_mv AT chenhsingyu isthemedianhourlyambulatoryheartraterangehelpfulinstratifyingmortalityriskamongnewlydiagnosedatrialfibrillationpatients
AT malikjohn isthemedianhourlyambulatoryheartraterangehelpfulinstratifyingmortalityriskamongnewlydiagnosedatrialfibrillationpatients
AT wuhautieng isthemedianhourlyambulatoryheartraterangehelpfulinstratifyingmortalityriskamongnewlydiagnosedatrialfibrillationpatients
AT wangchunli isthemedianhourlyambulatoryheartraterangehelpfulinstratifyingmortalityriskamongnewlydiagnosedatrialfibrillationpatients